Effect of drug pretreatment on CBrCl3-induced liver injury.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001966:Bromine / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control*; D002725:Chloroform / Q000627:therapeutic use*; D004347:Drug Interactions; D005234:Fatty Liver / Q000139:chemically induced; D006846:Hydrocarbons, Halogenated / Q000037:antagonists & inhibitors / Q000627:therapeutic use* / Q000633:toxicity; D050356:Lipid Metabolism; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D009336:Necrosis; D010545:Peroxides / Q000096:biosynthesis; D010634:Phenobarbital / Q000627:therapeutic use; D010655:Phenylenediamines / Q000627:therapeutic use; D011335:Proadifen / Q000627:therapeutic use; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism
D006846:Hydrocarbons, Halogenated; D010545:Peroxides; D010655:Phenylenediamines; D014280:Triglycerides; D002725:Chloroform; D011335:Proadifen; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001966:Bromine; D010634:Phenobarbital